Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study

Autor: Xie, Yizhao, Li, Yi, Zhang, Yinbin, Zhang, Shuqun, Li, Wei, Guan, Xiaoxiang, Zhao, Yannan, Gong, Chengcheng, Hu, Xichun, Zhang, Jian, Cao, Enying, Wang, Leiping, Ge, Rui, Wang, Biyun
Zdroj: In Clinical Breast Cancer June 2019 19(3):e452-e458
Databáze: ScienceDirect